Tensentric LLC (“Tensentric” or the “Company”), a provider of design, development, and manufacturing services for the healthcare and MedTech industries, announced today that Daniel A. Eckert, a healthcare industry veteran, has joined its Board of Directors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250902538778/en/

“We are delighted to welcome Dan to Tensentric’s Board of Directors. His deep experience across the healthcare and medical products sectors will be invaluable as we continue scaling our business and building on our strong position in the Medical Device, IVD, Life Sciences and Cell and Gene Therapy markets,” said Cathy Falbo, Chief Executive Officer of Tensentric.

“I am excited to partner with Cathy and the Tensentric team to deliver innovative design and manufacturing solutions to leading and emerging healthcare device manufacturers. We believe Tensentric is uniquely positioned to provide customized product design and development solutions to support the growth strategies of these companies,” said Dan Eckert.

Eckert has served as CEO, President, COO, and Director of multiple private and publicly traded companies ranging in size from $10 million to $2 billion+ in revenue. His leadership spans venture-backed, private equity-backed, and publicly traded businesses across distribution, medical products, healthcare IT, and laboratory diagnostics. Notably, he led the $1 billion+ clinical diagnostics division of Fisher Scientific; LABSCO, a $400 million business backed by Frazier Healthcare (acquired by McKesson in 2016); and StatLab, a $100 million anatomic pathology manufacturer and distributor backed by Cressey & Company (acquired by Audax and Linden Capital in 2020). He currently serves as Chairman & CEO of Aqueous Health, a direct-to-consumer diagnostics company he founded in 2023.

About Tensentric

Based in Boulder, Colorado, Tensentric provides outsourced design, engineering, prototyping and assembly services for leading Medical Technology, In-Vitro Diagnostic and Life Sciences companies. Since its founding in 2009, the Company has quickly established itself as a leading contract development partner, known for its differentiated team of engineers and experience working on the most cutting-edge development projects in the industry. https://tensentric.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250902538778/en/